Lew M A
Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Annu Rev Med. 1989;40:87-97. doi: 10.1146/annurev.me.40.020189.000511.
Invasive candidiasis has become an important cause of morbidity and mortality in patients receiving aggressive antineoplastic chemotherapy, in recipients of bone marrow transplants, and in other patient groups. The illness provides the clinician with few clues to its nature or presence. This paper reviews developments over the past three decades in the laboratory diagnosis of this important infection.